Presence of a carboxy-terminal pseudorepeat and disease-like pseudohyperphosphorylation critically influence tau’s interaction with microtubules in axon-like processes
Open accessThe DOI matches its Crossref record; 39 of the 39 references it cites were found in a registry or an index.
Abstract
A current challenge of cell biology is to investigate molecular interactions in subcellular compartments of living cells to overcome the artificial character of in vitro studies. To dissect the interaction of the neuronal microtubule (MT)-associated protein tau with MTs in axon-like processes, we used a refined fluorescence decay after photoactivation approach and single-molecule tracking. We found that isoform variation had only a minor influence on the tau–MT interaction, whereas the presence of a C-terminal pseudorepeat region (PRR) greatly increased MT binding by a greater-than-sixfold reduction of the dissociation rate. Bioinformatic analysis revealed that the PRR contained a highly conserved motif of 18 amino acids. Disease-associated tau mutations in the PRR (K369I, G389R) did not influence apparent MT binding but increased its dynamicity. Simulation of disease-like tau hyperphosphorylation dramatically diminished the tau–MT interaction by a greater-than-fivefold decrease of the association rate with no major change in the dissociation rate. Apparent binding of tau to MTs was similar in axons and dendrites but more sensitive to increased phosphorylation in axons. Our data indicate that under the conditions of high MT density that prevail in the axon, tau’s MT binding and localization are crucially affected by the presence of the PRR and tau hyperphosphorylation.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Biopython: freely available python tools for computational molecular biology and bioinformatics
Cock, P. J. A., Antao, T., Chang, J. T., Chapman, B. A., Cox, C. J., Dalke, A., Friedberg, I., Hamelryck, T., Kauff, F., Wilczynski, B., et al. (2009) · Bioinformatics · doi:10.1093/bioinformatics/btp163 · Cited by 6,080 · cited 1×
“The resulting hits were extracted by a self-written python script with the help of the biopython library (Python Software Foundation, www.python.org/psf/; Cock et al., 2009).”
MethodThe Pfam protein families database: towards a more sustainable future
Finn, R. D., Coggill, P., Eberhardt, R. Y., Eddy, S. R., Mistry, J., Mitchell, A. L., Potter, S. C., Punta, M., Qureshi, M., Sangrador-Vegas, A., et al. (2016) · Nucleic Acids Research · doi:10.1093/nar/gkv1344 · Cited by 5,975
HMMER web server: interactive sequence similarity searching
Finn, R. D., Clements, J., & Eddy, S. R. (2011) · Nucleic Acids Research · doi:10.1093/nar/gkr367 · Cited by 5,952
Reducing Endogenous Tau Ameliorates Amyloid ß-Induced Deficits in an Alzheimer's Disease Mouse Model
Roberson, E. D., Scearce-Levie, K., Palop, J. J., Yan, F., Cheng, I. H., Wu, T., Gerstein, H., Yu, G.-Q., & Mucke, L. (2007) · Science · doi:10.1126/science.1141736 · Cited by 1,892 · cited 1×
“Changes in tau localization and a gain of toxic function are considered to have a central role in the disease process (Rapoport et al., 2002; Roberson et al., 2007).”
BackgroundLewis, J., McGowan, E., Rockwood, J., Melrose, H., Nacharaju, P., Van Slegtenhorst, M., Gwinn-Hardy, K., Murphy, M. P., Baker, M., Yu, X., et al. (2000) · Nature Genetics · doi:10.1038/78078 · Cited by 1,371 · cited 2×
“…antibody detects paired helical filaments of AD patients, recognizes NFTs and pretangles in various mouse models, and was used for immunization experiments aimed at decreasing tau pathology (Lewis et al., 2000; Augustinack et al., 2002; Boutajangout et al., 2011; Mondragon-Rodriguez et al., 2014).”
Tau pathology and neurodegeneration
Spillantini, M. G., & Goedert, M. (2013) · The Lancet Neurology · doi:10.1016/s1474-4422(13)70090-5 · Cited by 1,133
Augustinack, J. C., Schneider, A., Mandelkow, E.-M., & Hyman, B. T. (2002) · Acta Neuropathologica · doi:10.1007/s004010100423 · Cited by 998 · cited 2×
“…antibody detects paired helical filaments of AD patients, recognizes NFTs and pretangles in various mouse models, and was used for immunization experiments aimed at decreasing tau pathology (Lewis et al., 2000; Augustinack et al., 2002; Boutajangout et al., 2011; Mondragon-Rodriguez et al., 2014).”
The MAP1 family of microtubule-associated proteins.
Dehmelt (2004) · Genome biology · doi:10.1186/gb-2004-6-1-204 · Cited by 972
Caspase cleavage of tau: Linking amyloid and neurofibrillary tangles in Alzheimer's disease
Gamblin, T. C., Chen, F., Zambrano, A., Abraha, A., Lagalwar, S., Guillozet, A. L., Lu, M., Fu, Y., Garcia-Sierra, F., LaPointe, N., et al. (2003) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1630428100 · Cited by 831
Tau is essential to β-amyloid-induced neurotoxicity
Rapoport, M., Dawson, H. N., Binder, L. I., Vitek, M. P., & Ferreira, A. (2002) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.092136199 · Cited by 807
Baas, P. W., Deitch, J. S., Black, M. M., & Banker, G. A. (1988) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.85.21.8335 · Cited by 742
Domains of tau Protein and Interactions with Microtubules
Gustke, N., Trinczek, B., Biernat, J., Mandelkow, E.-M., & Mandelkow, E. (1994) · Biochemistry · doi:10.1021/bi00198a017 · Cited by 655 · cited 3×
“In addition, regions flanking the MBD could be important because they increase tau’s assembly-promoting activity and modulate its binding to MTs in vitro and in nonneuronal cells (Brandt and Lee, 1993; Gustke et al., 1994; Leger et al., 1994; Preuss et al., 1997).”
BackgroundProjection domains of MAP2 and tau determine spacings between microtubules in dendrites and axons
Chen, J., Kanai, Y., Cowan, N. J., & Hirokawa, N. (1992) · Nature · doi:10.1038/360674a0 · Cited by 601
Proline-directed and non-proline-directed phosphorylation of PHF-tau
Morishima-Kawashima, M., Hasegawa, M., Takio, K., Suzuki, M., Yoshida, H., Titani, K., & Ihara, Y. (1995) · Journal of Biological Chemistry · doi:10.1074/jbc.270.2.823 · Cited by 557
Tau protein binds to microtubules through a flexible array of distributed weak sites.
Butner, K. A., & Kirschner, M. W. (1991) · The Journal of cell biology · doi:10.1083/jcb.115.3.717 · Cited by 550
Inhibition of neuronal maturation in primary hippocampal neurons from tau deficient mice
Dawson, H. N., Ferreira, A., Eyster, M. V., Ghoshal, N., Binder, L. I., & Vitek, M. P. (2001) · Journal of Cell Science · doi:10.1242/jcs.114.6.1179 · Cited by 527
Tau stabilizes microtubules by binding at the interface between tubulin heterodimers
Kadavath, H., Hofele, R. V., Biernat, J., Kumar, S., Tepper, K., Urlaub, H., Mandelkow, E., & Zweckstetter, M. (2015) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1504081112 · Cited by 524 · cited 3×
“Bioinformatic and biochemical studies show that the MTbinding domain (MBD) of tau consists of three or four repeat regions (RRs), which bind to MTs via small groups of evolutionarily conserved residues (Lee et al., 1989; Butner and Kirschner, 1991; Goode and Feinstein, 1994; Kadavath et al., 2015a; Sundermann et al.,…”
BackgroundResultThe microtubule binding domain of tau protein
Lee, G., Neve, R. L., & Kosik, K. S. (1989) · Neuron · doi:10.1016/0896-6273(89)90050-0 · Cited by 500 · cited 2×
“Bioinformatic and biochemical studies show that the MTbinding domain (MBD) of tau consists of three or four repeat regions (RRs), which bind to MTs via small groups of evolutionarily conserved residues (Lee et al., 1989; Butner and Kirschner, 1991; Goode and Feinstein, 1994; Kadavath et al., 2015a; Sundermann et al.,…”
BackgroundMonoclonal antibody PHF‐1 recognizes tau protein phosphorylated at serine residues 396 and 404
Otvos, L., Feiner, L., Lang, E., Szendrei, G. I., Goedert, M., & Lee, V. M. (1994) · Journal of Neuroscience Research · doi:10.1002/jnr.490390607 · Cited by 488 · cited 2×
“mutants in which phosphorylation was either mimicked or blocked at the PHF-1 site (positions S396 and S404 (Otvos et al., 1994)).”
BackgroundMethodDittgen, T., Nimmerjahn, A., Komai, S., Licznerski, P., Waters, J., Margrie, T. W., Helmchen, F., Denk, W., Brecht, M., & Osten, P. (2004) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0407976101 · Cited by 485
Protein sequence and mass spectrometric analyses of tau in the Alzheimer's disease brain
Hasegawa, M., Morishima-Kawashima, M., Takio, K., Suzuki, M., Titani, K., & Ihara, Y. (1992) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)41890-x · Cited by 430 · cited 1×
“Tau is subject to many posttranslational modifications in health and disease, which are likely to affect its localization and function (Hasegawa et al., 1992; Watanabe et al., 1993; MorishimaKawashima et al., 1995; Morris et al., 2015).”
BackgroundPhosphorylation determines two distinct species of tau in the central nervous system
Papasozomenos, S. C., & Binder, L. I. (1987) · Cell Motility · doi:10.1002/cm.970080303 · Cited by 420 · cited 2×
“This implies that the real kinetic constants of tau differ between these compartments, which may be due to the higher phosphorylation state of dendritic tau (Papasozomenos and Binder, 1987; Mandell and Banker, 1996; Maas et al., 2000).”
BackgroundGoode, B., & Feinstein, S. (1994) · The Journal of cell biology · doi:10.1083/jcb.124.5.769 · Cited by 399
Insights into the mechanism of microtubule stabilization by Taxol
Xiao, H., Verdier-Pinard, P., Fernandez-Fuentes, N., Burd, B., Angeletti, R., Fiser, A., Horwitz, S. B., & Orr, G. A. (2006) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0603704103 · Cited by 319
Boutajangout, A., Ingadottir, J., Davies, P., & Sigurdsson, E. M. (2011) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2011.07337.x · Cited by 306 · cited 2×
“…antibody detects paired helical filaments of AD patients, recognizes NFTs and pretangles in various mouse models, and was used for immunization experiments aimed at decreasing tau pathology (Lewis et al., 2000; Augustinack et al., 2002; Boutajangout et al., 2011; Mondragon-Rodriguez et al., 2014).”
Panda, D., Samuel, J. C., Massie, M., Feinstein, S. C., & Wilson, L. (2003) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1633508100 · Cited by 280
Jeganathan, S., Hascher, A., Chinnathambi, S., Biernat, J., Mandelkow, E.-M., & Mandelkow, E. (2008) · Journal of Biological Chemistry · doi:10.1074/jbc.m805300200 · Cited by 278 · cited 2×
“The results are consistent with previous in vitro data, for which phosphomimicking mutations in the PHF-1 site had been combined with mutations in other epitopes recognized by Alzheimer diagnostic antibodies (AT8, AT100); here only small effects on MT polymerization were observed (Jeganathan et al., 2008).”
ResultPark, S.-Y., & Ferreira, A. (2005) · The Journal of Neuroscience · doi:10.1523/jneurosci.1125-05.2005 · Cited by 262
In vivo phosphorylation sites in fetal and adult rat tau
Watanabe, A., Hasegawa, M., Suzuki, M., Takio, K., Morishima-Kawashima, M., Titani, K., Arai, T., Kosik, K. S., & Ihara, Y. (1993) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(19)74447-0 · Cited by 231
Maas, T., Eidenmüller, J., & Brandt, R. (2000) · Journal of Biological Chemistry · doi:10.1074/jbc.m000389200 · Cited by 226 · cited 6×
“Many of the physiological and pathological phosphorylation sites are located in regions that flank the MBD and might modulate tau’s interaction with MTs and other cellular components (Maas et al., 2000; Eidenmuller et al., 2001; Ding et al., 2006; Combs et al., 2011; Kiris et al., 2011; Xia et al., 2015).”
BackgroundResultInfluentialSelf-citationFolding of the Tau Protein on Microtubules
Kadavath, H., Jaremko, M., Jaremko, Ł., Biernat, J., Mandelkow, E., & Zweckstetter, M. (2015) · Angewandte Chemie International Edition · doi:10.1002/anie.201501714 · Cited by 153 · cited 3×
“Our data are consistent with results from recent in vitro experiments, where regions, which are involved in tau’s binding to MTs have been identified by NMR (Kadavath et al., 2015a; Kadavath et al., 2015b).”
BackgroundResultDifferential effect of three‐repeat and four‐repeat tau on mitochondrial axonal transport
Stoothoff, W., Jones, P. B., Spires‐Jones, T. L., Joyner, D., Chhabra, E., Bercury, K., Fan, Z., Xie, H., Bacskai, B., Edd, J., et al. (2009) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2009.06316.x · Cited by 135
Tau interaction with microtubules in vivo
Samsonov, A., Yu, J.-Z., Rasenick, M., & Popov, S. V. (2004) · Journal of Cell Science · doi:10.1242/jcs.01531 · Cited by 129
Tackenberg, C., & Brandt, R. (2009) · The Journal of Neuroscience · doi:10.1523/jneurosci.3590-09.2009 · Cited by 127 · cited 2×
“…culture experiments using PHP-tau provided evidence for a neurotoxic effect of soluble tau as a result of structural changes induced by cumulative, high-stoichiometric, and stable tau phosphorylation (Fath et al., 2002; Shahani et al., 2006; Tackenberg and Brandt, 2009; Golovyashkina et al., 2015).”
BackgroundSelf-citationEidenmüller, J., Fath, T., Hellwig, A., Reed, J., Sontag, E., & Brandt, R. (2000) · Biochemistry · doi:10.1021/bi001290z · Cited by 117 · cited 2×
“We showed that such pseudohyperphosphorylated tau constructs (PHP-tau) mimic key structural and functional aspects of hyperphosphorylated tau (Eidenmuller et al., 2000, 2001; Maas et al., 2000).”
BackgroundSelf-citationTau physiology and pathomechanisms in frontotemporal lobar degeneration
Bodea, L., Eckert, A., Ittner, L. M., Piguet, O., & Götz, J. (2016) · Journal of Neurochemistry · doi:10.1111/jnc.13600 · Cited by 104 · cited 1×
“In addition, dysfunction related to posttranslational modifications leading to MT depolymerization and impaired axonal transport may play a role (Bodea et al., 2016).”
BackgroundShahani, N., Subramaniam, S., Wolf, T., Tackenberg, C., & Brandt, R. (2006) · The Journal of Neuroscience · doi:10.1523/jneurosci.4245-05.2006 · Cited by 81
Self-citationPseudohyperphosphorylation Has Differential Effects on Polymerization and Function of Tau Isoforms
Combs, B., Voss, K., & Gamblin, T. C. (2011) · Biochemistry · doi:10.1021/bi2010569 · Cited by 41 · cited 2×
“Many of the physiological and pathological phosphorylation sites are located in regions that flank the MBD and might modulate tau’s interaction with MTs and other cellular components (Maas et al., 2000; Eidenmuller et al., 2001; Ding et al., 2006; Combs et al., 2011; Kiris et al., 2011; Xia et al., 2015).”
BackgroundNeuronal degeneration, synaptic defects, and behavioral abnormalities in tau45-230 transgenic mice
Lang, A. E., Riherd Methner, D. N., & Ferreira, A. (2014) · Neuroscience · doi:10.1016/j.neuroscience.2014.06.017 · Cited by 35 · cited 1×
“…to be an early event in AD (Reifert et al., 2011; Flores-Rodriguez et al., 2015) and may produce neurotoxic fragments (Park and Ferreira, 2005; Lang et al., 2014), generate products that show increased release from neurons (Kanmert et al., 2015), or produce fragments with a modified MT…”
Background
Cited by
Propagation of Tau aggregates and neurodegeneration
Goedert, M., Eisenberg, D. S., & Crowther, R. A. (2017) · Annual Review of Neuroscience · doi:10.1146/annurev-neuro-072116-031153 · Cited by 632
Kent, S. A., Spires-Jones, T. L., & Durrant, C. S. (2020) · Acta Neuropathologica · doi:10.1007/s00401-020-02196-w · Cited by 446
Alzheimer's disease and type 2 diabetes: a critical assessment of the shared pathological traits
Chatterjee, S., & Mudher, A. (2018) · Frontiers in Neuroscience · doi:10.3389/fnins.2018.00383 · Cited by 270
“This novel mechanism has been particularly effective in resolving the paradoxical observation that despite regulating microtubule dynamics, alterations in tau levels may not interfere with axonal transport (Janning et al., 2014; Niewidok et al., 2016).”
BackgroundSynaptic dysfunction in Alzheimer's disease: Mechanisms and therapeutic strategies
Chen, Y., Fu, A. K. Y., & Ip, N. Y. (2019) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2018.11.006 · Cited by 258
Microtubules gate tau condensation to spatially regulate microtubule functions
Tan, R., Lam, A. J., Tan, T., Han, J., Nowakowski, D. W., Vershinin, M., Simó, S., Ori-McKenney, K. M., & McKenney, R. J. (2019) · Nature Cell Biology · doi:10.1038/s41556-019-0375-5 · Cited by 231
Metadata
- Authors
- Niewidok, B., Igaev, M., Sündermann, F., Janning, D., Bakota, L., & Brandt, R.
- Venue
- Molecular Biology of the Cell
- Published
- 2016-11-07
- Volume
- 27
- Issue
- 22
- Pages
- 3537-3549
- ISSN
- 1059-1524 (ISSN-L)
- 1939-4586
- OpenAlex
- W2507989145
- Cited by
- 62
- References
- 39
- FWCI
- 5.02
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.